Fig. 1
Study flow. In 80 KD patients who received IFX therapy from January 2016 to March 2023, 53 achieved fever resolution, and 27 required additional IVIG-after-IFX therapy
Fig. 1 | Pediatric Rheumatology
Study flow. In 80 KD patients who received IFX therapy from January 2016 to March 2023, 53 achieved fever resolution, and 27 required additional IVIG-after-IFX therapy
Pediatric Rheumatology